About Cytoscape
Cytoscape is a Healthcare company based in Seattle (United States) founded in 2002. It develops platforms for visualizing molecular interaction networks and biological pathways. It operates on a B2B model. Its focus areas include Biotechnology, Bioinformatics and Network Visualization. Similar companies include Metabolon, Helix, Syapse, Benchling and BioAge Labs and 3 more; 8 of its 8 listed similar companies have raised funding.
Company details
Cytoscape develops platforms for visualizing molecular interaction networks and biological pathways, focusing on providing healthcare solutions, advancing biotech innovations, bioinformatics, and network visualization. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Seattle, United States
- SectorsHealthcare
- Website cytoscape.org
- Social X
Similar companies to Cytoscape
Cytoscape has 8 listed similar companies in our database, 8 of them funded. They include Metabolon, Helix, Syapse, Benchling and BioAge Labs, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| metabolon.com | 2000 | Morrisville, United States | $165.87M | 189 | Solutions for biomarker discovery and diagnostic testing are provided. | |
| helix.com | 2015 | San Francisco, United States | $435M | – | Genomic database for clinical research is provided. | |
| syapse.com | 2008 | San Francisco, United States | $221.1M | 209 | Developer of precision medicine for the treatment of cancer | |
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. | |
| ingenuity.com | 1998 | Redwood, United States | $20.4M | 30 | Genomic data is analyzed and interpreted via web-based applications. | |
| precisionneuro.io | 2021 | New York, United States | $182.65M | 22 | Brain-computer interfaces developed for medical treatment and drug development. | |
| genuitysci.com | 2013 | Boston, United States | $515M | – | AI-based omics data analysis solutions are provided to researchers. |
Detailed similar companies of Cytoscape
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cytoscape
Websites that share an audience with Cytoscape (cytoscape.org).
Websites whose visitors overlap most with Cytoscape. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| plotly.com | 83% | 624.5K | #82,168 | View details | |
| witstream.com | 69% | – | – | View details | |
| mgrc.com.my | 28% | 1.9K | #6,940,535 | View details | |
| ingenuity.com | 21% | 24.3K | #619,156 | View details |
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Cytoscape (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cytoscape
Cytoscape was founded in 2002.
Cytoscape is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Cytoscape develops platforms for visualizing molecular interaction networks and biological pathways, focusing on providing healthcare solutions, advancing biotech innovations, bioinformatics, and network visualization. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.